comparemela.com

Page 14 - Innovation Fund Denmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Growth and massive AI developments in 2022

Copenhagen, April 28, 2023 Announcement no. 2-2023Inside Information/Company announcement The media tech company Hypefactors presents the growth for 2022. Key figures are: ARR: 37%. | April 28, 2023

Ear-EEG device aims to detect Alzheimer s and Parkinson s years before symptoms appear

Ear EEG Tests for Alzheimer s and Parkinson s at Home

T-cell vaccine for COVID-19 may last longer than current vaccines

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. Focusing on the T-cell instead, Penn State researchers partnered with Evaxion Biotech on a study that was the first to demonstrate the effectiveness of an artificial intelligence-generated vaccine in a live viral challenge model. Such a vaccine may provide long-lasting immunity against future emerging variants and could be used as a model for other seasonal viral diseases like the flu.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.